Incidence of Langerhans cell histiocytosis in children: A population-based study

Pediatric Blood and Cancer

Volumn 51, Issue 1, 2008, Pages 76-81

  Stålemark, Helen ^a   Laurencikas, Evaldas ^a   Karis, Jenny ^a   Gavhed, Désirée ^a   Fadeel, Bengt ^b   Henter, Jan Inge ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Etiology; Incidence; Infection; Langerhans cell histiocytosis; Season

Indexed keywords

STEROID;

ADOLESCENT; ARTICLE; AUTUMN; CANCER INCIDENCE; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; INFANT; LABORATORY DIAGNOSIS; MALE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; RARE DISEASE; SCHOOL CHILD; SEASONAL VARIATION; SUMMER; WINTER;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPIDEMIOLOGIC MEASUREMENTS; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INCIDENCE; INFANT; MALE; SEASONS; SWEDEN;

EID: 44149115243     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21504     Document Type: Article

References (38)

1. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1-11.
2. Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:247-258.
3. Arceci RJ. The histiocytosis: The fall of the Tower of Babel. Eur J Cancer 1999;35:747-767.
4. Henter JI, Tondini C, Prichard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004;50:157-174.
5. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:72-80.
6. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001;138: 728-734.
7. Titgemeyer C, Grois N, Minkov M, et al. Med Pediatr Oncol 2001;37:108-114.
8. Lau L, Krafchik B, Trebo MM, et al. Cutaneus Langerhans cell histiocytosis in children under one year. Pediatr Blood Cancer 2006;46:66-71.
9. Bernstrand C, Sandstedt B, Åhström L, et al. Long term follow up of Langerhans cell histiocytosis a: 39 years experience at a single centre. Acta Pediatr 2005;94:1073-1084.
10. Willis B, Ablin A, Weinberg V, et al. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996;14: 2073-2082.
11. Komp DM. Long-term sequelae of histiocytosis X. Am J Pediatr Hematol Oncol 1981;3:163-168.
12. Egeler M, Neglia JP, Puccetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993;71:865-873.
13. Haupt R, Nanduri V, Grazia Calevo M, et al. Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004;42:438-444.
14. Jubran RF, Marachelian A, Dorey F, et al. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 2005;45:37-42.
15. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - A clonal proliferative disease. N Engl J Med 1994;331:154.
16. Egeler RM, Willman CL. Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders? Med Pediatr Oncol 2000;35:426.
17. Fadeel B, Henter JI. Langerhans cell histiocytosis: Neoplasia or unbridled inflammation? Trends Immunol 2003;24:409-410.
18. Bernstrand C, Carstensen H, Jakobsen B, et al. Immunogenetic heterogeneity in single system and multisystem Langerhans cell histiocytosis. Pediatr Res 2003;54:30-36.
19. Leahy MA, Krejci SM, Friednash M, et al. Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 1993;101:642-645.
20. McClain K, Weiss RA. Viruses and Langerhans cell histiocytosis: Is there a link? Br J Cancer Suppl 1994;23:34-36.
21. Shimakage M, Sasagawa T, Kimura M, et al. Expression of Epstein-Barr virus in Langerhans cell histiocytosis. Human Pathol 2004;35:862-868.
22. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997;29:157-166.
23. Calming U, Jacobsson H, Henter JI. Detection of Langerhans cell histiocytosis with somatostatin analogue scintigraphy: A preliminary report. Med Pediatr Oncol 2000;35:462-467.
24. Carstensen H, Ornvold K. The epidemiology of Langerhans cell histiocytosis in children in Denmark, 1975-89. Med Pediatr Oncol 1993;21:387-388 (abstract).
25. Alston RD, Tatevossian RG, McNally RJ, et al. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer 2007;48:555-560.
26. Muller J, Garami M, Hauser P, et al. Hungarian experience with Langerhans cell histiocytosis in childhood. Pediatr Hematol Oncol 2006;23:135-142.
27. Glass AG, Miller RW. US mortality from Letterer-Siwe disease 1960-64. Pediatrics 1968;42:364-367.
28. Bhatia S, Nesbit ME, Jr., Egeler RM, et al. Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr 1997;130:774-784.
29. Hamre M, Hedberg J, Buckley J, et al. Langerhans cell histiocytosis: An exploratory epidemiologic study of 177 cases. Med Pediatr Oncol 1997;28:92-97.
30. Nicholson HS, Egeler RM, Nesbit ME. The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:379-384.
31. Chen RL, Lin KS, Chang WH, et al. Childhood Langerhans cell histiocytosis increased during El Nino 1997-98: A report from Taiwan Pediatric Oncology Group. Acta Peadiatr Taiwan 2003; 44:14-20.
32. Laman JD, Leenen PJ, Annels NE, et al. Langerhans-cell histiocytosis insight into DC biology. Trends Immunol 2003;24: 190-196.
33. Calming U, Henter J-I. Elevated ESR and thrombocytosis may be valuable markers of active disease in Langerhans cell histiocytosis. Acta Paediatr 1998;87:1085-1087.
34. Rosso DA, Karis J, Braier JL, et al. Elevated serum levels of the decoy receptor osteoprotegerin in children with Langerhans cell histiocytosis. Pediatr Res 2006;59:281-286.
35. Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell Histiocytosis. Br J Cancer Suppl 1994;23:S37-S40.
36. Egeler RM, Favara BE, van Meurs M, et al. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood 1999;94:4195-4201.
37. Andersson-By U, Tani E, Andersson U, et al. Tumor necrosis factor, interleukin-11 and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2004;26:706-711.
38. McClain K, Jin H, Gresik V, et al. Langerhans cell histiocytosis: Lack of viral etiology. Am J Hematol 1994;47:16-20.